Joint Bleeds in Adults: Not All Pharmacokinetics

Commentary by David Stephensen (PhD), Physiotherapist, Kent Haemophilia & Thrombosis Centre, Canterbury, and the Haemophilia Centre, Royal London Hospital, London, UK Prophylaxis at a dose that maintains factor levels above target reduces the frequency of joint bleeds in people with haemophilia – but often it does not prevent them completely. Perhaps the target factor level …

Read more